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The drawbacks of conventional letters in visual acuity measurements have been long acknowledged, including the nonuniform
discriminability across the letter set1 and high test–retest variability.2 Apart from the introduction of the ETDRS chart,3 surprisingly
few alterations have been made to the standard visual acuity test in the last 60 years. Although the Landolt C target, with equal
discriminability between different orientations, has been recognized as the gold standard for measuring visual acuity,4 this stimulus
is not ideal for use in the clinical setting, owing in part to the small number of possible alternatives. Furthermore, ‘‘reading the
letters on the chart’’ is arguably the most familiar test of vision to those undergoing an eye examination. With the advent of novel
therapies for conditions such as age-related macular degeneration (AMD), what is increasingly needed is a letter chart with lower
test–retest variability that does not require a change in task for the patient. Shah et al.5 propose the clinical use of vanishing
optotypes,6 which may well meet these conditions and possibly provide more accurate measures of underlying functional retinal
ganglion cell density than conventional letter stimuli, at least when viewed extrafoveally. These letter targets are pseudo-high-pass,
in that they have dark strokes with light edges or vice versa and a mean luminance equal to the surround. Detection and
recognition are equal in the fovea; the targets vanish as soon as the recognition limit is reached.
The authors measured detection and recognition acuity for conventional and vanishing optotypes in the fovea and at 108
eccentricity in two psychophysically trained healthy individuals, with and without optical blur. The article reports several key
findings; while comparable in the fovea, a separation between detection and recognition acuity for ‘‘vanishing’’ optotypes became
apparent outside the fovea. This, together with a relative robustness of peripheral recognition acuity to optical blur, lends support
to the notion that recognition acuity for these targets is sampling limited outside the fovea. Furthermore, and perhaps most
important clinically, the authors confirm previous findings7 that discriminability is more uniform across the entire letter set when
low spatial frequency content is removed. They conclude that more repeatable visual acuity measurements may be obtained with
vanishing optotypes than with conventional letters.
Further experiments are required to explore the performance of vanishing optotypes in naive observers in research and clinical
settings, in clinical trials, and in disease, but these initial findings are encouraging for an improvement on current methods without
altering the task of the patient.
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